We are investigating the fairness of the proposed sale of ProAssurance Corporation (NYSE: PRA) (“ProAssurance”) to The Doctors Companies (“TDC”) for $25.00 per share in cash.
If you remain a ProAssurance shareholder and question the fairness of the price, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.
Why is there an investigation?
On March 19, 2025, after the markets closed, ProAssurance announced that it had agreed to be sold to TDC for $25.00 per share in cash.
“We are investigating whether the ProAssurance Board of Directors acted in the best interests of ProAssurance shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the price agreed upon is fair to ProAssurance shareholders, as well as whether all material information regarding the transaction has been fully disclosed.”